journal
MENU ▼
Read by QxMD icon Read
search

Journal of Pharmaceutical Policy and Practice

journal
https://www.readbyqxmd.com/read/30094032/perceptions-of-the-malaysian-general-public-on-community-pharmacy-based-weight-management-services
#1
Rohit Kumar Verma, Thomas Paraidathathu, Nur Akmar Taha, Wei Wen Chong
Background: Obesity is now widely regarded as a main contributor to poor health. Involvement of community pharmacists can be a valuable tool in obesity management. However, there is still a lack of data in Malaysia on the potential involvement of and opportunities for community pharmacists in providing weight management services. Thus, it is essential to investigate the perceptions of the general public on weight management services in the community pharmacy setting. To evaluate the general public's perceptions on weight management services by community pharmacists in terms of perceived availability, utilization and factors influencing acceptability of services...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/30079250/nps-medicinewise-20-years-of-change
#2
Lynn Maria Weekes, Suzanne Blogg, Sharene Jackson, Kerren Hosking
The cost and potential harms of medicines and other health technologies are issues of concern for governments and third party payers of health care. Various means have been demonstrated to promote appropriate evidence-based use of these technologies as a way to reduce waste and unintended variation. Since 1998, Australia has had a national organisation responsible for large scale programs to address safe, effective and cost effective use of health technologies. This article reviews 20 years of experience for NPS MedicineWise (NPS)...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/30034811/a-qualitative-exploration-of-knowledge-attitudes-and-practices-of-hospital-pharmacists-towards-adverse-drug-reaction-reporting-system-in-lahore-pakistan
#3
Rabia Hussain, Mohamed Azmi Hassali, Furqan Hashmi, Maryam Farooqui
Background: Medication safety is a major public health concern and there are well established pharmacovigilance programmes in developed countries. However, there is scarcity of literature on the issue in low and middle income countries. In this context, the current study was aimed to evaluate the knowledge, attitudes and practices of hospital pharmacists towards medication safety and ADR reporting in Lahore, Pakistan. Methods: A qualitative approach was used to conduct this study...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/30026953/comment-on-hernandez-vasquez-et-al-a-bibliometric-analysis-of-the-global-research-on-biosimilars
#4
Hillel P Cohen
A bibliometric analysis provided by Hernandez-Vasquez et al. listed the institutions that have published most extensively in the field of biosimilars. Sandoz and Novartis International were considered as separate entities, but are both are divisions of the same parent company. When considered as a single entity for purposes of tracking publications, Sandoz-Novartis is among the leaders in the number of articles published about biosimilars.
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/30002854/article-2-longitudinal-study-assessing-the-one-year-effects-of-supervision-performance-assessment-and-recognition-strategy-spars-to-improve-medicines-management-in-uganda-health-facilities
#5
Birna Trap, Richard Musoke, Anthony Kirunda, Martin Olowo Oteba, Martha Embrey, Dennis Ross-Degnan
Background: In late 2010, Uganda introduced a supervision, performance assessment, and recognition strategy (SPARS) to improve staff capacity in medicines management in government and private not-for-profit health facilities. This paper assesses the impact of SPARS in health facilities during their first year of supervision. Methods: SPARS uses health workers trained as Medicines Management Supervisors (MMS) to supervise health facilities and address issues identified through indicatorbased performance assessment in five domains: stock management, storage management, ordering and reporting, prescribing quality, and dispensing quality...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29951208/regulatory-requirements-for-the-registration-of-generic-medicines-and-format-of-drug-dossiers-procedures-in-sri-lanka-in-comparison-with-selected-regulatory-authorities
#6
D Thambavita, P Galappatthy, R L Jayakody
Background: The regulatory requirements for approval of generic medicines and the format of compiling drug dossiers vary among regulatory authorities. The variation is particularly wide between High-income countries (HIC) and lower and middle-income countries (LMIC) with different regulatory frameworks. In this study, document requirements for approval of generic products, approval timelines, and consideration of bioequivalence and/or biowaiver data by Regulatory Authorities (RAs) of 10 selected jurisdictions was studied...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29930813/assessment-of-primary-labeling-of-medicines-manufactured-by-nepalese-pharmaceutical-industries
#7
Ramesh Sharma Poudel, Shakti Shrestha, Santosh Thapa, Bhupendra Kumar Poudel, Muniraj Chhetri
Background: Appropriate labeling of marketed medicines is necessary to fulfill the regulatory provisions and ensure patient medication safety. This study aimed to assess the primary labeling of medicines manufactured and marketed by Nepalese pharmaceutical industries. Methods: We assessed the primary labeling of all medicines available at the pharmacy of Chitwan Medical College Teaching Hospital (CMCTH), Chitwan, Nepal, between November 2017 to December 2017. Medicines were assessed as required by Drug Standard Regulation, 2043 (1986 AD) of Nepal...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29796284/provider-preferences-for-postoperative-analgesia-in-obese-and-non-obese-patients-undergoing-ambulatory-surgery
#8
Anthony H Bui, David L Feldman, Michael L Brodman, Peter Shamamian, Ronald N Kaleya, Meg A Rosenblatt, Debra D'Angelo, Donna Somerville, Santosh Mudiraj, Patricia Kischak, I Michael Leitman
Background: Few guidelines exist on safe prescription of postoperative analgesia to obese patients undergoing ambulatory surgery. This study examines the preferences of providers in the standard treatment of postoperative pain in the ambulatory setting. Methods: Providers from five academic medical centers within a single US city were surveyed from May-September 2015. They were asked to provide their preferred postoperative analgesic routine based upon the predicted severity of pain for obese and non-obese patients...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29744109/evaluating-inter-rater-reliability-of-indicators-to-assess-performance-of-medicines-management-in-health-facilities-in-uganda
#9
Belinda Blick, Stella Nakabugo, Laura F Garabedian, Morries Seru, Birna Trap
Background: To build capacity in medicines management, the Uganda Ministry of Health introduced a nationwide supervision, performance assessment and recognition strategy (SPARS) in 2012. Medicines management supervisors (MMS) assess performance using 25 indicators to identify problems, focus supervision, and monitor improvement in medicines stock and storage management, ordering and reporting, and prescribing and dispensing. Although the indicators are well-recognized and used internationally, little was known about the reliability of these indicators...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29713474/the-belgian-commitment-to-pharmaceutical-quality-a-model-policy-to-improve-quality-assurance-of-medicines-available-through-humanitarian-and-development-programs
#10
EDITORIAL
Raffaella Ravinetto, Tim Roosen, Catherine Dujardin
Today, a combination of globalization of pharmaceutical production, lack of regulatory harmonization, and weakness of Medicines Regulatory Authorities, creates the "perfect conditions" for poor-quality medicine to circulate in the global market and to penetrate the less-regulated countries. Medicines regulation is the responsibility of the national regulatory authorities in the recipient country, but in the poorer countries, in practice, the responsibility of supply of quality-assured medicines is often taken by Non-Governmental Organizations and other implementers...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29651337/weaving-the-health-and-pharmaceutical-care-agenda-through-the-themes-of-the-commonwealth-heads-of-government-meeting-chogm-london-2018
#11
EDITORIAL
Victoria Rutter, Amy Hai Yan Chan, Chloe Tuck, Lina Bader, Zaheer-Ud-Din Babar, Ian Bates
The biennial Commonwealth Heads of Government Meeting (CHOGM) this year is based around four key themes: prosperity, fairness, sustainability and security. This is an opportune time to consider the role of pharmacists in healthcare delivery, and particularly their contribution to achieving the United Nations Sustainable Development Goals (SDGs). As a member of the Commonwealth Health Professions Alliance (CHPA), the Commonwealth Pharmacists Association (CPA) has been working to ensure that pharmacy-related aspects of health are represented in the advocacy papers submitted by Civil Society...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29632669/insights-into-early-stage-of-antibiotic-development-in-small-and-medium-sized-enterprises-a-survey-of-targets-costs-and-durations
#12
Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, Kevin Outterson, Jens Plahte, Francesco Ciabuschi, John-Arne Røttingen
Background: Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug innovation. To design effective solutions, a greater understanding is needed of actual antibiotic discovery and development costs and timelines. Small and medium-sized enterprises (SMEs) undertake most discovery and early phase development for antibiotics and other drugs...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29610667/a-survey-of-knowledge-attitude-and-practices-of-private-retail-pharmacies-staff-in-tuberculosis-care-study-from-dera-ismail-khan-city-pakistan
#13
Tehmina Mustafa, Yasir Shahzad, Ayyaz Kiani
Background: In order to engage pharmacies in tuberculosis (TB) care, a survey was conducted in the Dera Ismail (DI) Khan City of the Khyber Pakhtoon Khwa province, Pakistan. The objectives were to; 1) characterize the retail pharmacies; 2) determine knowledge of the staff on various aspects of pulmonary TB; 3) determine practices related to the sale of anti-TB drugs, and referrals of presumptive TB patient, and willingness to participate in the National Tuberculosis Control Programme's (NTP) Directly Observed Treatment Short-Course (DOTS) strategy...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29599984/a-bibliometric-analysis-of-the-global-research-on-biosimilars
#14
Akram Hernández-Vásquez, Christoper A Alarcon-Ruiz, Guido Bendezu-Quispe, Daniel Comandé, Diego Rosselli
Background: Biosimilars could be a promising option to help decrease healthcare costs and expand access to treatment. There is no previous evidence of a global bibliometric analysis on biosimilars. Therefore, we aimed to assess the quantity and quality of worldwide biosimilars research. Methods: We performed a bibliometric analysis using documents about biosimilars published until December 2016 in journals indexed in Scopus. We extracted the annual research, languages, countries, journals, authors, institutions, citation frequency, and the metrics of journals...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29564139/pharmaceutical-company-spending-on-research-and-development-and-promotion-in-canada-2013-2016-a-cohort-analysis
#15
Joel Lexchin
Background: Competing claims are made about the amount of money that pharmaceutical companies spend on research and development (R&D) versus promotion. This study investigates this question in the Canadian context. Methods: Two methods for determining industry-wide figures for spending on promotion were employed. First, total industry spending on detailing and journal advertising for 2013-2016 was abstracted from reports from QuintilesIMS. Second, the mean total promotion spending for the years 2002-2005 was used to estimate total spending for 2013-2016...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29456865/a-real-world-example-of-coverage-with-evidence-development-in-australia-ipilimumab-for-the-treatment-of-metastatic-melanoma
#16
Hansoo Kim, Samantha Comey, Karl Hausler, Greg Cook
Background: Australian Government subsidisation of ipilimumab for the treatment of patients with metastatic melanoma was conditional on the sponsor entering a 'managed entry scheme' to assess the 2-year overall survival rate in metastatic melanoma patients who received ipilimumab in the first year of Pharmaceutical Benefits Scheme listing. Methods: All unresectable stage IIIc / IV metastatic melanoma patients treated with at least one dose of ipilimumab therapy in Australia from the PBS listing date to a time point 12 months later (i...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29435335/health-care-for-all-effective-community-supported-healthcare-with-innovative-use-of-telemedicine-technology
#17
EDITORIAL
Tariq Kazim Shah, Tasneem Tariq, Roger Phillips, Steve Davison, Adam Hoare, Syed Shahzad Hasan, Zaheer-Ud-Din Babar
Almost half of the world's total population reside in rural and remote areas and a large number of these people remain deprived of most basic facilities like healthcare and education. It is deemed impossible for government with scarce resources in developing countries to open and run a health facility in every remote community using conventional means. One increasingly popular unconventional mean is the use of existing technology to improve exchange of medical information for the purpose of improving health of underprivileged communities...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29387420/barriers-and-facilitators-to-hospital-pharmacists-engagement-in-medication-safety-activities-a-qualitative-study-using-the-theoretical-domains-framework
#18
Alemayehu B Mekonnen, Andrew J McLachlan, Jo-Anne E Brien, Desalew Mekonnen, Zenahebezu Abay
Background: Hospital pharmacists play a central role in medication safety activities. However, in Ethiopia, this role has been launched recently and little is known regarding the current status of this extended service. Using the Theoretical Domains Framework (TDF), we aimed to identify the barriers and facilitators to hospital pharmacists' engagement in medication safety activities across various public hospitals in the Amhara region of Ethiopia. Methods: Eight focus group discussions, using an interview guide that was drawn upon the TDF, were conducted with 44 hospital pharmacists to explore their beliefs regarding their involvement in clinical services...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29372061/analysis-of-changes-in-trends-in-the-consumption-rates-of-benzodiazepines-and-benzodiazepine-related-drugs
#19
Miguel Angel Fernández García, Antonio Olry de Labry Lima, Ingrid Ferrer Lopez, Clara Bermúdez-Tamayo
Background: To analyse trends in the rates of consumption of benzodiazepine (BZD) anxiolytics, BZD hypnotics and non-BZD hypnotics and the association with contextual factors. Methods: Descriptive time series study. Units of analysis were monthly dose per inhabitant per day (DID) and dose per medical card per day(DCD) of benzodiazepine(BZD anxiolytics(BZD-A), BZD hypnotics(BZD-H) and non-BZD hypnotics(Non-BZD-H) between January 2006-December 2015. We analysed 6 primary healthcare districts(PHD) and used defined daily doses (DDDs) to calculate the monthly DIDs(overall and by ATC group)...
2018: Journal of Pharmaceutical Policy and Practice
https://www.readbyqxmd.com/read/29299319/exploring-the-extended-role-of-the-community-pharmacist-in-improving-blood-pressure-control-among-hypertensive-patients-in-a-developing-setting
#20
Afia Frimpomaa Asare Marfo, Frances Thelma Owusu-Daaku
Background: In most developing countries including Ghana, there is scant literature on the involvement of the community pharmacist in the care of patients with chronic conditions such as hypertension and blood pressure control. The objective of the study was to evaluate the effect of a pharmaceutical care model on blood pressure control and adherence among hypertensive patients. Methods: This was a quasi experimental design and the primary outcome measure was a change in systolic and diastolic blood pressure...
2017: Journal of Pharmaceutical Policy and Practice
journal
journal
48346
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"